Susan Mathison, MD
Otolaryngology · Fargo, NDNPI 1952469165
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,199 of the $11,436 with a category attached, or 71.7%. It is spread thinly across 27 manufacturers, the largest accounting for just 22.0%. Reporting peaked in 2021 at $3,551 and has fallen 95.3% since, to $166 in 2025. Among otolaryngology clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $116.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Acclarent, Inc$2K
- Medical Device Business Services, Inc.$2K
- Stryker$2K
- Galderma Laboratories, L.p.$795
- AbbVie$626
- plus $947 from 21 others
What the payments were for
- Speaking & faculty fees$4504%
- Travel & lodging$8,19972%
- Food & beverage$2,78124%
- Gifts$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 7 | $2,516 |
| Acclarent, Inc | 8 | $2,466 |
| Medical Device Business Services, Inc. | 7 | $2,439 |
| Stryker | 13 | $1,647 |
| Galderma Laboratories, L.p. | 9 | $795 |
| AbbVie(2 entities) | 21 | $626 |
| Aerin Medical Inc. | 7 | $399 |
| Inspire Medical Systems, Inc. | 2 | $90 |
| Phadia US Inc. | 3 | $50 |
| Merz North America, Inc. | 2 | $45 |
| Revance Therapeutics, Inc. | 1 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Merck | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Novartis | 1 | $20 |
| Sanofi | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| GSK | 1 | $18 |
| Optinose US, Inc. | 1 | $18 |
| UCB, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Organogenesis Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$2,487
- PROPEL$2,487
- XPRESS ENT DILATION SYSTEM$851
- SCOPIS ENT$442
- VIVAER STYLUS$168
- RHINAER STYLUS$168
- BOTOX COSMETIC$139
How this compares
$11,436 in reported general payments places this provider in the 95th percentile of 26 otolaryngology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 29 | $1,171 |
| Famotidine | 41 | $614 |
| Omeprazole | 26 | $416 |
| Fluticasone Propionate | 19 | $380 |
| Nortriptyline Hcl | 14 | $265 |
| Azelastine Hcl | 12 | $235 |
| Montelukast Sodium | 18 | $162 |
| Mupirocin | 18 | $113 |
| Cephalexin | 28 | $100 |
| Oxycodone Hcl | 44 | $90 |
| Ondansetron Hcl | 27 | $58 |
| Prednisone | 20 | $54 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Fargo
- Michael ShinnersFargo$8K
- Yusuf AgamawiFargo$3K
- Brent NicholsFargo$2K
- Matthew MillerFargo$1K
- Andrew TerrellFargo$485
- Paul WilliamsFargo$392
- James FriskFargo$126
- David TsenFargo$65
- Alan BrunsFargo$62
- Marie-Pierre CharronBismarck$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.